a screaming buy, page-4

In fact, one other NASDAQ company that was trading below cash backing was Tetralogic (J. Kevin Buchi's baby) but has sinced bounced back hard (over 300%) on no news, just the realisation that it was extremely oversold, much like Benitec.

I expect it will bounce soon once this anomoly is realised, so hang in there if you can.  I cannot recall another time when this sort of opportunity to buy such a disruptive company has ever arisen for biotech investors.